一种在小鼠中具有抗结核活性的新型合成化合物：乙胺丁醇（右旋-2,2'-（乙二胺基）-二-1-丁醇）。 - Suppr

Suppr

超能文献

A new synthetic compound with antituberculous activity in mice: ethambutol (dextro-2,2'-(ethylenediimino)-di-l-butanol).

作者信息

THOMAS J P, BAUGHN C O, WILKINSON R G, SHEPHERD R G

出版信息

Am Rev Respir Dis. 1961 Jun;83:891-3. doi: 10.1164/arrd.1961.83.6.891.

DOI:10.1164/arrd.1961.83.6.891

PMID:13776497

Abstract

摘要

相似文献

A new synthetic compound with antituberculous activity in mice: ethambutol (dextro-2,2'-(ethylenediimino)-di-l-butanol).

Am Rev Respir Dis. 1961 Jun;83:891-3. doi: 10.1164/arrd.1961.83.6.891.

[ANTITUBERCULOUS ACTIVITY OF DEXTRO-2,2'-(ETHYLENEDIIMINO)-DI-1-BUTANOL (ETHAMBUTOL). (II) COMBINED EFFECT OF ETHAMBUTOL AND ISONIAZID].

Kekkaku. 1964 Jun;39:191-6.

EXPERIMENTAL AND CLINICAL STUDIES ON 2-2'-(ETHYLENEDIIMINO)-DI-1-BUTANOL.

Sci Rep Res Inst Tohoku Univ Med. 1965 Mar;12:45-52.

AN EFFECT OF ETHAMBUTOL, 2,2'(ETHYLENEDIIMINO)-DI-1-BUTANOL-, ON THE STRUCTURE AND ACTIVITY OF ALCOHOL DEHYDROGENASE.

Nature. 1965 Jan 16;205:241-2. doi: 10.1038/205241a0.

ANTITUBERCULOSIS ACTIVITY OF DEXTRO-2,2'-(ETHYLENEDIIMINO)-DI-1-BUTANOL (ETHAMBUTOL) (I).

Kekkaku. 1964 May;39:155-60.

[THERAPEUTIC EFFECTS OF ETHAMBUTOL (DEXTRO-2,2'-(ETHYLENEDIIMINO)-DI-1-BUTANOL) AND HON (ALPHA-HYDROXY-GAMMA-OXO-L-NORVALINE) ON EXPERIMENTAL TUBERCULOSIS].

Kekkaku. 1964 Feb;39:69-73.

Stability of Ethambutol [d-2,2'-(ethylenediimino)-di-I-butanol] resistant mycobacteria grown in the absence of Ethambutol.

Indian J Exp Biol. 1965 Jul;3(3):176-7.

[Dextro-2,2'-(ethyenediimino)-di-1-butanol dihydrochloride in experimental tuberculosis therapy].

Arzneimittelforschung. 1962 Apr;12:359-60.

[The synthesis of L-(+)-2,2'-(ethylenediimino)-di-1-butanol (ethambutol)].

Cesk Farm. 1966 Sep;15(7):367-8.

[Antimycobacterial activity of serum from patient under chemotherapy including 2,2'-(ethylenediimino)-di-1-Butanol (Ebutol)].

Kekkaku. 1965 Nov;40(11):505-10.

引用本文的文献

Targeting the Heart of Mycobacterium: Advances in Anti-Tubercular Agents Disrupting Cell Wall Biosynthesis.

Pharmaceuticals (Basel). 2025 Jan 9;18(1):70. doi: 10.3390/ph18010070.

Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement.

Front Pharmacol. 2024 Sep 19;15:1441147. doi: 10.3389/fphar.2024.1441147. eCollection 2024.

Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments.

Clin Microbiol Rev. 2023 Dec 20;36(4):e0008823. doi: 10.1128/cmr.00088-23. Epub 2023 Nov 30.

Genetic polymorphism related to ethambutol outcomes and susceptibility to toxicity.

Front Genet. 2023 Apr 20;14:1118102. doi: 10.3389/fgene.2023.1118102. eCollection 2023.

The past, present and future of tuberculosis treatment.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Dec 25;51(6):657-668. doi: 10.3724/zdxbyxb-2022-0454.

Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line.

Genet Mol Biol. 2023 Jan 23;46(1 Suppl 2):e20220261. doi: 10.1590/1678-4685-GMB-2022-0261. eCollection 2023.

Derivation of a Precise and Consistent Timeline for Antibiotic Development.

Antibiotics (Basel). 2022 Sep 12;11(9):1237. doi: 10.3390/antibiotics11091237.

Multicomponent crystals of anti-tuberculosis drugs: a mini-review.

RSC Adv. 2020 Oct 7;10(61):37134-37141. doi: 10.1039/d0ra06478e.

Computational prediction and validation of specific EmbR binding site on PknH.

Synth Syst Biotechnol. 2021 Nov 26;6(4):429-436. doi: 10.1016/j.synbio.2021.11.006. eCollection 2021 Dec.

-Trifluoromethylthiolated Sulfonimidamides and Sulfoximines: Anti-microbial, Anti-mycobacterial, and Cytotoxic Activity.

ACS Med Chem Lett. 2019 Sep 11;10(10):1457-1461. doi: 10.1021/acsmedchemlett.9b00285. eCollection 2019 Oct 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验